Novartis, Wyeth Unit Spar Over ReFacto Patent
Pharmaceutical giant Novartis AG has asserted its rights over two patents for several anti-hemophiliac treatments in an ongoing battle with Wyeth subsidiary Genetics Institute over who legally owns the formula for...To view the full article, register now.
Already a subscriber? Click here to view full article